Since the publication of the February 28 issue of IBO (see IBO 2/28/18), which included estimated figures for the IBO Life Science and Analytical Instrument Indexes (LSA Indexes), quarterly and annual estimates have been finalized for three companies: Bio-Rad Laboratories Life Science, Merck KGaA Life Science and NanoString Technologies. The updated financial results affect the IBO Life […]

In what is viewed as a step forward for NGS-based clinical testing, the US Centers for Medicare & Medicaid Services (CMS) announced this month a final National Coverage Determination (NCD) for FDA-approved NGS tests for advanced cancer (defined as either recurrent, relapsed, refractory, metastatic, or advanced stages III or IV) patients as long as certain […]